Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/134377
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry

AuthorsPessoa de Magalhães, Roberto J.; Vidriales, Maria Belén; Paiva, Bruno; Fernández, Carlos; García-Sanz, Ramón; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Lécrevisse, Quentin; Blanco, Juan F.; Martínez-López, Joaquín; Sobral da Costa, E.; Ocio, Enrique M. CSIC ORCID ; Pérez-Andrés, Martin; Lahuerta, Juan José; San Miguel, Jesús F. CSIC ORCID; Orfao, Alberto CSIC ORCID
Issue Date2013
PublisherFerrata Storti Foundation
CitationHaematologica 98(1): 79-86 (2013)
AbstractMultiple myeloma remains largely incurable. However, a few patients experience more than 10 years of relapsefree survival and can be considered as operationally cured. Interestingly, long-term disease control in multiple myeloma is not restricted to patients with a complete response, since some patients revert to having a profile of monoclonal gammopathy of undetermined significance. We compared the distribution of multiple compartments of lymphocytes and dendritic cells in the bone marrow and peripheral blood of multiple myeloma patients with long-term disease control (n=28), patients with newly diagnosed monoclonal gammopathy of undetermined significance (n=23), patients with symptomatic multiple myeloma (n=23), and age-matched healthy adults (n=10). Similarly to the patients with monoclonal gammopathy of undetermined significance and symptomatic multiple myeloma, patients with long-term disease control showed an expansion of cytotoxic CD8 + T cells and natural killer cells. However, the numbers of bone marrow T-regulatory cells were lower in patients with long-term disease control than in those with symptomatic multiple myeloma. It is noteworthy that B cells were depleted in patients with monoclonal gammopathy of undetermined significance and in those with symptomatic multiple myeloma, but recovered in both the bone marrow and peripheral blood of patients with long-term disease control, due to an increase in normal bone marrow B-cell precursors and plasma cells, as well as pre-germinal center peripheral blood B cells. The number of bone marrow dendritic cells and tissue macrophages differed significantly between patients with long-term disease control and those with symptomatic multiple myeloma, with a trend to cell count recovering in the former group of patients towards levels similar to those found in healthy adults. In summary, our results indicate that multiple myeloma patients with long-term disease control have a constellation of unique immune changes favoring both immune cytotoxicity and recovery of B-cell production and homing, suggesting improved immune surveillance.
DescriptionSpanish Myeloma Group (GEM) and Grupo Castellano-Leones de Gammapatias Monoclonales, cooperative study groups: et al.
Publisher version (URL)http://dx.doi.org/10.3324/haematol.2012.067272
URIhttp://hdl.handle.net/10261/134377
DOI10.3324/haematol.2012.067272
Identifiersdoi: 10.3324/haematol.2012.067272
issn: 0390-6078
e-issn: 1592-8721
Appears in Collections:(IBMCC) Artículos

Files in This Item:
File Description SizeFormat
flowcytometry.pdf2,56 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

PubMed Central
Citations

49
checked on May 16, 2022

SCOPUSTM   
Citations

89
checked on May 20, 2022

WEB OF SCIENCETM
Citations

92
checked on May 21, 2022

Page view(s)

352
checked on May 21, 2022

Download(s)

241
checked on May 21, 2022

Google ScholarTM

Check

Altmetric

Dimensions


Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.